Bingham Osborn & Scarborough’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,427
| Closed | -$561K | – | 86 |
|
|
2021
Q3 | $561K | Buy |
2,427
+126
| +5% | +$29.1K | 0.04% | 81 |
|
|
2021
Q2 | $528K | Sell |
2,301
-36
| -2% | -$8.26K | 0.04% | 82 |
|
|
2021
Q1 | $437K | Buy |
2,337
+813
| +53% | +$152K | 0.03% | 88 |
|
|
2020
Q4 | $257K | Sell |
1,524
-1,009
| -40% | -$170K | 0.02% | 115 |
|
|
2020
Q3 | $375K | Sell |
2,533
-172
| -6% | -$25.5K | 0.03% | 111 |
|
|
2020
Q2 | $444K | Sell |
2,705
-24
| -0.9% | -$3.94K | 0.04% | 92 |
|
|
2020
Q1 | $379K | Buy |
2,729
+939
| +52% | +$130K | 0.04% | 98 |
|
|
2019
Q4 | $235K | Sell |
1,790
-26
| -1% | -$3.41K | 0.02% | 148 |
|
|
2019
Q3 | $203K | Buy |
+1,816
| New | +$203K | 0.02% | 150 |
|
|
2019
Q2 | – | Sell |
-1,756
| Closed | -$228K | – | 149 |
|
|
2019
Q1 | $228K | Sell |
1,756
-1,264
| -42% | -$164K | 0.02% | 131 |
|
|
2018
Q4 | $349K | Buy |
+3,020
| New | +$349K | 0.04% | 98 |
|